Robert I. Blum - 14 Mar 2024 Form 4 Insider Report for CYTOKINETICS INC (CYTK)

Role
President & CEO, Director
Signature
/s/ John Faurescu, attorney-in-fact for Mr. Blum
Issuer symbol
CYTK
Transactions as of
14 Mar 2024
Net transactions value
$0
Form type
4
Filing time
18 Mar 2024, 18:52:13 UTC
Previous filing
07 Mar 2024
Next filing
07 Jun 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYTK Common Stock Award $0 +61,490 +15% $0.000000 461,221 14 Mar 2024 Direct F1
holding CYTK Common Stock 2,083 14 Mar 2024 by Trust 1 F2
holding CYTK Common Stock 2,083 14 Mar 2024 by Trust 2 F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYTK Incentive Stock Option (Right to Buy) Award $0 +1,568 $0.000000 1,568 14 Mar 2024 Common Stock 1,568 $63.75 Direct F4
transaction CYTK Non-Qualified Stock Option (Right to Buy) Award $0 +69,464 $0.000000 69,464 14 Mar 2024 Common Stock 69,464 $63.75 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Award comprised of Restricted Stock Units that will vest over 3-years, with 40% vesting on the 1-year anniversary of the date of grant, an addiitional 40% vesting on the 2-year anniversary of the date of grant, and the remaining 20% vesting on the 3-year anniversary of the date of grant.
F2 Shares held by The Bridget Blum 2003 Irrevocable Trust.
F3 Shares held by The Brittany Blum 2003 Irrevocable Trust.
F4 Award comprised of Non Statutory Stock Options that will vest and become exercisable over 4 years in monthly installments starting April 15, 2024, with the final monthly installment vesting on March 14, 2028.